Rivus Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion of a $132 million Series B financing led by...
InnoCare Pharma, a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced that BTK inhibitor orelabrutinib has been granted priority review...
Orion’s collaboration partner Bayer announced the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for the oral androgen...
Implementing severity-based field triage leads to faster treatment and less disability for stroke patients. The research presented today at the Society of NeuroInterventional Surgery's...
Xandar Kardian, a rapidly-growing, Toronto-based company that develops contactless health monitoring solutions powered by digital ultra wide-band radar signal processing, officially announced a strategic...
